Dual versus triple therapy for uncomplicated brucellosis: A retrospective cohort study | Zendy

Rawan O Al-Madfaa | Zendy; Mai Alalawi | Zendy; Lana O. Basudan | Zendy; Shahad F Alhejaili | Zendy; Khalid Eljaaly | Zendy; Tariq A. Madani | Zendy; Abrar K. Thabit | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dual versus triple therapy for uncomplicated brucellosis: A retrospective cohort study

Author(s) -

Rawan O Al-Madfaa,

Mai Alalawi,

Lana O. Basudan,

Shahad F Alhejaili,

Khalid Eljaaly,

Tariq A. Madani,

Abrar K. Thabit

Publication year - 2020

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.12741

Subject(s) - medicine , brucellosis , retrospective cohort study , clinical endpoint , brucella , doxycycline , regimen , erythrocyte sedimentation rate , cohort , brucella melitensis , surgery , pediatrics , antibiotics , immunology , clinical trial , microbiology and biotechnology , biology

Brucellosis is a zoonotic disease caused by Brucella spp. affecting multiple body systems and may lead to complications. Saudi Arabia is a country where brucellosis is endemic. This study aimed to describe the epidemiological characteristics of uncomplicated brucellosis and to assess outcomes of different antibiotic regimens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research